Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,040,329
+$1,453,437 QoQ
Shares Held
5,036
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#538
of 2,003 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. LLY ranks #1 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
|
3,962 | $1,006,229 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,040,329 | 5,036 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,586,892 | 4,987 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,398,118 | 5,023 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,726,492 | 4,884 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,769,027 | 4,835 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,790,100 | 4,589 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,530,356 | 4,573 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,825,488 | 4,318 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,342,647 | 5,901 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,590,741 | 5,901 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,343,629 | 5,736 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,899,964 | 5,399 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,535,305 | 5,406 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,845,882 | 5,375 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,038,460 | 5,572 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $2,602,320 | 8,048 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,623,669 | 8,092 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,349,952 | 8,206 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,180,756 | 7,895 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,860,645 | 8,053 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,987,872 | 8,661 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,626,641 | 8,707 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,263,598 | 7,484 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,126,728 | 7,612 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,269,111 | 7,730 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,081,738 | 7,798 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||